Previous close | 6.51 |
Open | 6.61 |
Bid | 6.61 x 400 |
Ask | 6.66 x 300 |
Day's range | 6.41 - 6.65 |
52-week range | 5.45 - 14.37 |
Volume | |
Avg. volume | 634,461 |
Market cap | 391.401M |
Beta (5Y monthly) | 1.32 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Hims & Hers Health, Enovis Corp and Health Catalyst are part of the Zacks Industry Outlook article.
Health Catalyst (HCAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
The average of price targets set by Wall Street analysts indicates a potential upside of 75.2% in Health Catalyst (HCAT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.